Navigation Links
Study Shows Patients & Nurses Benefit From Continuous Vigilance Monitoring
Date:3/31/2009

Quicker detection of potential medical problems

HONOLULU, March 31 /PRNewswire/ -- A new study published in The Journal of Nursing Administration shows there are significant benefits for patients and nurses when continuous vigilance monitoring is used in medical settings. "The outcomes were definitive," stated Dr. Patrick Sullivan, President and CEO of Hoana Medical, Inc. "Using such monitoring provides an early alert to RNs about potential medical problems, so they can intervene in a more timely way and, as a result, improve patient safety."

The 12 month study was conducted at three U.S. Veterans Health Administration (VHA) hospitals, utilizing the LifeBed Patient Vigilance System(TM). The system is comprised of a mattress coverlet which is embedded with sensors that measure heart rate (HR), respiratory rate (RR) and provides a bed exit alert for fall prevention. The patient simply lies down and the sensors immediately monitor HR and RR. No electrodes, cuffs or other connections are required, which improves patient comfort. Patient data is continuously relayed to a bedside computer display unit. If the patient's HR or RR fluctuates outside normal limits or if a fall-risk patient leaves the bed the system alerts nursing staff both audibly and visually.

The study found that the timeliness of the early warning system improved early recognition of patient distress, resulting in RNs spending more time with patients. Previous studies have found that the more time a RN spends with patients the better the outcome.

"The reality of the nationwide nursing shortage is that, at most hospitals, RNs do not have the time to constantly monitor all of their patients," said Dr. Heather Herdman, Chief Strategic Officer of Hoana Medical, Inc. "Monitoring generally takes place about every four hours and it's not always done by an RN. By then, if a patient is in distress, it can be a life threatening situation." In fact, respiratory rate change is the number one predictor of a patient being at risk for medical complications that are cardio-respiratory in nature.

In addition to providing early recognition of patient distress, earlier independent research studies showed that fall rates drop between 40 and 90 percent through continuous vigilance monitoring.

"Clearly the results show that technology can benefit both the medical community and the patient," said Sullivan. "The patients get the help they need in a very timely manner and RNs know the technology will help them provide the quality care that's needed."

Study note: The study was conducted at James A. Haley Veterans' Hospital - Tampa, FL; VA Palo Alto Health Care System - Palo Alto, CA; and Richard L. Roudebush VA Medical Center - Indianapolis, IN.

LifeBed is a product of Hoana Medical, Inc. Hoana Medical, founded in 2001, is a privately held medical device company based in Honolulu, HI. To learn more about Hoana, go to: www.hoana.com


'/>"/>
SOURCE Hoana Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: